Corrigendum to "Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis" [Vascul. Pharmacol. 101(2018) 29-37].

Corrigendum to "Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis" [Vascul. Pharmacol. 101(2018) 29-37]. Vascul Pharmacol. 2020 May 14;:106698 Authors: Mei X, Zhou L, Zhang T, Lu B, Sheng Y, Ji L PMID: 32417323 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32417323?dopt=Abstract

Source: Vascular Pharmacology - May 13, 2020 Category: Drugs & Pharmacology Authors: Mei X, Zhou L, Zhang T, Lu B, Sheng Y, Ji L Tags: Vascul Pharmacol Source Type: research

More News: Diabetes | Drugs & Pharmacology | Endocrinology | Vitamin A